Xi Zhang Hao Tang Jun Fan Rui Wang Yunwei Han Song Su Yu Gan Fangyi Peng Mingyue Rao Jianwen Zhang Bo Li Xiaoli Yang
10.3389/fimmu.2022.1051130
Front Immunol
2022 Dec 23;13:1051130.
albumin paclitaxel carrelizumab case report cholangiocarcinoma cisplatin conversion therapy gemcitabine
CC BY
https://pubmed.ncbi.nlm.nih.gov/36618353/
Bile Duct Neoplasms / drug therapy Bile Duct Neoplasms / pathology Cholangiocarcinoma / drug therapy Cholangiocarcinoma / pathology
Bile Duct Neoplasms / drug therapy Bile Duct Neoplasms / pathology Cholangiocarcinoma / drug therapy Cholangiocarcinoma / pathology Case Reports Research Support, Non-U.S. Gov't Bile Ducts, Intrahepatic / pathology Deoxycytidine / therapeutic use Gemcitabine Humans Deoxycytidine Gemcitabine
PMC9816130
36618353
Case report: A report of the complete pathological response of intrahepatic cholangiocarcinoma after conversion therapy
2022